Literature DB >> 16583243

Calcium and phosphate balance in adolescents on home nocturnal haemodialysis.

Daljit K Hothi1, Elizabeth Harvey, Elizabeth Piva, Laura Keating, Donna Secker, Denis F Geary.   

Abstract

Studies in adults show superior serum phosphate and parathyroid hormone (PTH) control on slow nocturnal haemodialysis (NHD) compared with conventional haemodialysis. We studied the progress of four children aged 12, 13, 14 and 16 years after they had been initiated on NHD. The follow-up period ranged from 6 months to 20 months. Biochemical indices of bone metabolism were collected prospectively. All four children were initially dialysed against a 1.5 mmol/l calcium bath. In two patients, owing to biochemical hypocalcaemic episodes, the dialysate calcium concentration was increased to 1.75 mmol/l. One patient became hypercalcaemic and received calcitonin for bone pain secondary to osteoporosis and was dialysed against a 1.0 mmol/l calcium bath. Including an evaluation of dietary intake, all four patients had a net positive calcium balance, ranging from 5.1 mmol/m2 body surface area (BSA) per day to 24.3 mmol/m2 BSA per day. A significant reduction in the pre-dialysis phosphate level was observed in all four patients, such that none required dietary restrictions or phosphate binders, and dialysate phosphate supplements of 0.8-2.03 mmol/l were employed to prevent hypophosphataemia. The (CaxPO4) dropped below 4.4 mmol(2) l(-2) in all four patients. Concurrently, significant reductions in intact PTH levels were seen in all four patients, but the level dropped to below normal range in two. In our cohort of patients, NHD rapidly lowered plasma phosphate and PTH levels, and additional dialysate phosphate and possibly calcium may be necessary to prevent bone demineralisation due to chronic losses and to prevent oversuppression of PTH.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16583243     DOI: 10.1007/s00467-006-0048-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  31 in total

Review 1.  Calciphylaxis and vascular calcification: a continuum of extra-skeletal osteogenesis.

Authors:  Sharon M Moe; Neal X Chen
Journal:  Pediatr Nephrol       Date:  2003-10       Impact factor: 3.714

2.  Phosphate kinetics during hemodialysis: Evidence for biphasic regulation.

Authors:  Elaine M Spalding; Paul W Chamney; Ken Farrington
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

3.  25-hydroxyvitamin D3 (calcifediol) therapy of juvenile renal osteodystrophy: beneficial effect on linear growth velocity.

Authors:  C B Langman; A T Mazur; R Baron; M E Norman
Journal:  J Pediatr       Date:  1982-05       Impact factor: 4.406

Review 4.  Special aspects of renal osteodystrophy in children.

Authors:  Isidro B Salusky; Beatriz G Kuizon; Harald Jüppner
Journal:  Semin Nephrol       Date:  2004-01       Impact factor: 5.299

5.  Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis.

Authors:  Goce B Spasovski; An R J Bervoets; Geert J S Behets; Ninoslav Ivanovski; Aleksander Sikole; Geert Dams; Marie-M Couttenye; Marc E De Broe; Patrick C D'Haese
Journal:  Nephrol Dial Transplant       Date:  2003-06       Impact factor: 5.992

6.  Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients.

Authors:  M E Solal; J L Sebert; B Boudailliez; A Marie; P Moriniere; J Gueris; R Bouillon; A Fournier
Journal:  J Clin Endocrinol Metab       Date:  1991-09       Impact factor: 5.958

7.  Phosphate dialytic removal: enhancement of phosphate cellular clearance by biofiltration (with acetate-free buffer dialysate).

Authors:  M Fischbach; G Hamel; U Simeoni; J Geisert
Journal:  Nephron       Date:  1992       Impact factor: 2.847

8.  A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia.

Authors:  K Amann; E Ritz; G Wiest; G Klaus; G Mall
Journal:  J Am Soc Nephrol       Date:  1994-04       Impact factor: 10.121

9.  Development of a nocturnal home hemodialysis (NHHD) program for children.

Authors:  Denis F Geary; Elizabeth Piva; Mukesh Gajaria; Jennifer Tyrrel; Gail Picone; Elizabeth Harvey
Journal:  Semin Dial       Date:  2004 Mar-Apr       Impact factor: 3.455

10.  Alteration of the circadian rhythm of intact parathyroid hormone and serum phosphate in women with established postmenopausal osteoporosis.

Authors:  W D Fraser; F C Logue; J P Christie; S J Gallacher; D Cameron; D S O'Reilly; G H Beastall; I T Boyle
Journal:  Osteoporos Int       Date:  1998       Impact factor: 5.071

View more
  11 in total

1.  Can dialysis modality influence cardiovascular outcome?

Authors:  Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2012-06-03       Impact factor: 3.714

Review 2.  Intensified hemodialysis in adults, and in children and adolescents.

Authors:  Julia Thumfart; Wolfgang Pommer; Uwe Querfeld; Dominik Müller
Journal:  Dtsch Arztebl Int       Date:  2014-04-04       Impact factor: 5.594

Review 3.  How have the past 5 years of research changed clinical practice in paediatric nephrology?

Authors:  Stephen D Marks
Journal:  Arch Dis Child       Date:  2007-04       Impact factor: 3.791

4.  Approach to the hypophosphatemic patient.

Authors:  Erik A Imel; Michael J Econs
Journal:  J Clin Endocrinol Metab       Date:  2012-03       Impact factor: 5.958

Review 5.  Mineral metabolism and bone abnormalities in children with chronic renal failure.

Authors:  Cheryl P Sanchez
Journal:  Rev Endocr Metab Disord       Date:  2008-01-04       Impact factor: 6.514

Review 6.  Home haemodialysis.

Authors:  Daljit K Hothi; Lynsey Stronach; Elizabeth Harvey
Journal:  Pediatr Nephrol       Date:  2012-11-03       Impact factor: 3.714

Review 7.  Chronic kidney disease: mineral and bone disorder in children.

Authors:  Katherine Wesseling-Perry; Isidro B Salusky
Journal:  Semin Nephrol       Date:  2013-03       Impact factor: 5.299

8.  Hemodiafiltration in a pediatric nocturnal dialysis program.

Authors:  Julia Thumfart; Christina V Puttkamer; Steffen Wagner; Uwe Querfeld; Dominik Müller
Journal:  Pediatr Nephrol       Date:  2014-02-18       Impact factor: 3.714

Review 9.  Reducing the burden of cardiovascular disease in children with chronic kidney disease: prevention vs. damage limitation.

Authors:  Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2021-06-18       Impact factor: 3.714

10.  Monitoring dialysis adequacy: history and current practice.

Authors:  Linda Ding; James Johnston; Maury N Pinsk
Journal:  Pediatr Nephrol       Date:  2021-01-05       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.